180 related articles for article (PubMed ID: 21469310)
1. [Relationship of psychiatrists to the pharmaceutical companies--part of, or the solution to, the problem].
Insel TR
Lege Artis Med; 2010 Sep; 20(9):630-1. PubMed ID: 21469310
[No Abstract] [Full Text] [Related]
2. [Conflict of interest viewed from over-sea reports regarding relationship between clinical psychiatry and drug industry].
Senba J
Seishin Shinkeigaku Zasshi; 2010; 112(11):1124-9. PubMed ID: 21351692
[No Abstract] [Full Text] [Related]
3. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?
Insel TR
JAMA; 2010 Mar; 303(12):1192-3. PubMed ID: 20332407
[No Abstract] [Full Text] [Related]
4. [Conflict of interest regarding clinical psychiatrist' relationship with global pharmaceutical industries].
Eguchi S
Seishin Shinkeigaku Zasshi; 2010; 112(11):1117-23. PubMed ID: 21351691
[No Abstract] [Full Text] [Related]
5. Ball or aerosol? Sin, soap and the pharmaceutical industry.
Ratcliff E
Australas Psychiatry; 2013 Feb; 21(1):27-31. PubMed ID: 23344801
[TBL] [Abstract][Full Text] [Related]
6. Study cites links to firms by psychiatrists.
Carey B
N Y Times Web; 2006 Apr; ():A23. PubMed ID: 16649281
[No Abstract] [Full Text] [Related]
7. US psychiatrist is fired from radio programme for not disclosing drug company ties.
Tanne JH
BMJ; 2008 Dec; 337():a2934. PubMed ID: 19066260
[No Abstract] [Full Text] [Related]
8. Who pays the piper?
Friedli L
Ment Health Today; 2003 Nov; ():8-9. PubMed ID: 14689593
[No Abstract] [Full Text] [Related]
9. [Financial conflict of interest in clinical psychiatry studies: a review].
Ulaş H; Binbay T; Alptekin K
Turk Psikiyatri Derg; 2008; 19(4):418-26. PubMed ID: 19110984
[TBL] [Abstract][Full Text] [Related]
10. Beyond a pejorative understanding of conflict of interest.
Williams-Jones B
Am J Bioeth; 2011 Jan; 11(1):1-2. PubMed ID: 21240793
[No Abstract] [Full Text] [Related]
11. [Increase in incidence of drug treatments, ethical principles and conflict of interest in cooperation with the pharmaceutical industry].
Hebebrand J; Blanz B; Herpertz-Dahlmann B; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 2012 May; 40(3):133-8. PubMed ID: 22774235
[No Abstract] [Full Text] [Related]
12. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
[TBL] [Abstract][Full Text] [Related]
13. Doctors and drug companies.
Blumenthal D
N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
[No Abstract] [Full Text] [Related]
14. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
Quan SF
J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
[No Abstract] [Full Text] [Related]
15. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
Chakrabarti A; Fleisher WP; Staley D; Calhoun L
Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
[TBL] [Abstract][Full Text] [Related]
16. 'Big pharma' and psychiatry: 'the devil is in the dyad'.
Anand S
Aust N Z J Psychiatry; 2012 Dec; 46(12):1118-9. PubMed ID: 23212138
[No Abstract] [Full Text] [Related]
17. How to manage conflicts of interest with industry?
Schowalter JE
Int Rev Psychiatry; 2008 Apr; 20(2):127-33. PubMed ID: 18386202
[TBL] [Abstract][Full Text] [Related]
18. Psychiatry has dangerous alliance with drug companies.
Mosher LR
Behav Healthc Tomorrow; 1999 Jun; 8(3):6. PubMed ID: 11645352
[No Abstract] [Full Text] [Related]
19. Ethics. Senate probe of research psychiatrists.
Kaiser J
Science; 2009 Jul; 325(5936):30. PubMed ID: 19574367
[No Abstract] [Full Text] [Related]
20. 'Interests' in medicine and the inadequacy of disclosure.
Kerridge I
Aust N Z J Psychiatry; 2012 Jun; 46(6):501-3. PubMed ID: 22679203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
